scholarly journals Surgery without Blood Transfusion for Giant Paraganglioma in a Jehovah's Witness Patient

2014 ◽  
Vol 7 (1) ◽  
pp. 233-238 ◽  
Author(s):  
Takuya Narita ◽  
Itsuto Hamano ◽  
Ayumu Kusaka ◽  
Hiromi Murasawa ◽  
Noriko Tokui ◽  
...  
Keyword(s):  
Blood Transfusion ◽  
Jehovah’S Witness ◽  
Jehovah's Witness ◽  
Witness Patient

scholarly journals Major liver surgery in a Jehovah’s Witness patient: challenges for safe surgery

2019 ◽  
pp. 24-26
Author(s):  
WY Lim ◽  
L Loh ◽  
SR Desai ◽  
SL Tien ◽  
BK Goh ◽  
...  
Keyword(s):  
Blood Transfusion ◽  
Patient Autonomy ◽  
Ethical Issues ◽  
Major Surgery ◽  
Blood Products ◽  
Jehovah’S Witness ◽  
Jehovah's Witness ◽  
Safe Surgery ◽  
Patient Consent ◽  
Witness Patient

Jehovah’s Witnesses presenting for major surgery run the risk of major bleeding, which is complicated by the refusal to accept blood transfusion. We present a case of a 63-year-old woman, a Jehovah’s Witness, who was diagnosed with hepatocellular carcinoma and advised for curative laparoscopic liver segmentectomy. Due to the risk of significant intraoperative haemorrhage, her perioperative care was coordinated in a multidisciplinary manner. Informed consent requires the physician to advise on the material risks of undertaking major surgery without blood transfusion and the possible alternatives. Conflicting ethical issues of patient autonomy and beneficence related to refusal of blood products also arise. Perioperative strategies to minimise blood loss, maximise haematopoiesis and tolerance of anaemia to facilitate safe surgery in such patients are also presented. Written patient consent obtained.

Use of recombinant human erythropoietin to avoid blood transfusion in a Jehovah's Witness requiring hemispherectomy

1993 ◽  
Vol 79 (4) ◽  
pp. 600-602 ◽  
Author(s):  
Steven J. Schiff ◽  
Steven L. Weinstein
Keyword(s):  
Blood Transfusion ◽  
Recombinant Human Erythropoietin ◽  
Recombinant Erythropoietin ◽  
Content Type ◽  
Jehovah’S Witness ◽  
Human Recombinant Erythropoietin ◽  
Jehovah's Witness ◽  
Human Erythropoietin ◽  
Witness Patient ◽  
Fine Print

✓ The use of perioperative human recombinant erythropoietin is described in a Jehovah's Witness patient. Despite significant anemia, the child's hematocrit was sufficiently increased by the use of erythropoietin so that a two-stage hemispherectomy could be performed without blood transfusion.

Staged repair for a chronic dissecting thoracic aortic aneurysm with no transfusion in a Jehovah's Witness patient

2007 ◽  
Vol 55 (6) ◽  
pp. 262-265 ◽  
Author(s):  
Takayuki Kadohama ◽  
Nobuyuki Akasaka ◽  
Tadahiro Sasajima ◽  
Kazutomo Goh ◽  
Nobuyoshi Azuma ◽  
...  
Keyword(s):  
Aortic Aneurysm ◽  
Thoracic Aortic Aneurysm ◽  
Jehovah’S Witness ◽  
Jehovah's Witness ◽  
Witness Patient

The Jehovah’s Witness Patient

2017 ◽  
pp. 341-351
Author(s):  
Chantal Lerminiaux ◽  
Philippe Van der Linden
Keyword(s):  
Jehovah’S Witness ◽  
Jehovah's Witness ◽  
Witness Patient

Bloodless Surgery in a Jehovah’s Witness Patient with a 12.7-kg Uterine Leiomyosarcoma

2007 ◽  
Vol 64 (4) ◽  
pp. 212-219 ◽  
Author(s):  
Nimesh P. Nagarsheth ◽  
Aryeh Shander ◽  
Robert Malovany ◽  
Jausheng Tzeng ◽  
Ibrahim Ibrahim
Keyword(s):  
Uterine Leiomyosarcoma ◽  
Jehovah’S Witness ◽  
Jehovah's Witness ◽  
Bloodless Surgery ◽  
Witness Patient

scholarly journals Successful treatment of total placenta previa by multidisciplinary therapy in a Jehovah’s Witness patient who refused blood transfusions

2018 ◽  
pp. bcr-2018-226486
Author(s):  
Sayaka Tachi ◽  
Noriko Yoneda ◽  
Satoshi Yoneda ◽  
Shigeru Saito
Keyword(s):  
Placenta Previa ◽  
Blood Transfusions ◽  
Multidisciplinary Therapy ◽  
Jehovah’S Witness ◽  
Blood Salvage ◽  
Jehovah's Witness ◽  
Balloon Catheters ◽  
Acute Normovolaemic Haemodilution ◽  
Witness Patient ◽  
Intraoperative Blood Salvage

A 35-year-old Jehovah’s Witness patient with total placenta previa was referred to our hospital at 30 weeks of gestation. She refused autologous and allogeneic blood transfusions, but agreed to receive acute normovolaemic haemodilution, intraoperative blood salvage and biological products. At 35 weeks, she underwent emergent caesarean delivery because of labour pains. Multidisciplinary therapy, including the insertion of balloon catheters into the bilateral common iliac arteries, acute normovolaemic haemodilution and intraoperative blood salvage, avoided hysterectomy; however, blood loss included amniotic fluid which was estimated to be 1910 mL. These treatments may be effective for total placenta previa in blood-refusal patients.

Sign in / Sign up

Export Citation Format

Share Document